Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic, Horizon Discovery Sign OEM Pact

NEW YORK (GenomeWeb) – Transgenomic and Horizon Discovery today announced they have entered into an OEM agreement, under which Transgenomic will incorporate Horizon Discovery's human genomic reference standards into its Multiplexed ICE COLD-PCR (MX-ICP) kits for research and clinical applications.

The MX-ICP technology allows simultaneous detection of multiple DNA mutations from a single sample.

"Incorporating Horizon's industry-leading controls into our MX-ICP kits supports our global commercialization campaign by providing customers and partners additional assurance of the exceptional performance of MX-ICP technology," Transgenomic CEO Paul Kinnon said in a statement.

Financial details of the agreement were not disclosed.

In 2014 the two firms collaborated on validating controls in the development of genetic diagnostic tests.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.